Lifetime substance misuse and 5-year incidence rates of emergent health problems among middle-aged adults

Journal of Addictive Diseases

Volumn 28, Issue 4, 2009, Pages 320-331

  Caspers, Kristin M ^a   Yucuis, Rebecca ^a   McKirgan, Lowell M ^a   Spinks, Ruth ^a   Arndt, Stephan ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Abuse; Alcohol; Health; Tobacco

Indexed keywords

ALCOHOL; CANNABIS; ILLICIT DRUG;

ADULT; ALCOHOL ABUSE; ALCOHOLISM; ARTICLE; CARDIOVASCULAR DISEASE; DRUG MISUSE; FEMALE; HEALTH CARE UTILIZATION; HEALTH HAZARD; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; ONSET AGE; PREDICTION; SUBSTANCE ABUSE; TOBACCO; TOBACCO DEPENDENCE;

ADOPTION; ADULT; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; COMORBIDITY; FEMALE; HEALTH SERVICES; HEALTH STATUS; HUMANS; INCIDENCE; INTERVIEW, PSYCHOLOGICAL; MALE; METABOLIC DISEASES; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SEX DISTRIBUTION; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 75149156521     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550880903182796     Document Type: Article

References (37)

1. Tetrault JM, Crothers K, Moore BA, Mehra R, Concato J, Fiellin DA. Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med 2007;167: 221-228
2. Moore BA, Augustson EM, Moser RP, Budney AJ. Respiratory effects of marijuana and tobacco use in a U.S. sample. J Gen Intern Med 2005; 20:33-37
3. Tashkin DP, Baldwin GC, Sarafian T, Dubinett S, Roth MD. Respiratory and immunologic consequences of marijuana smoking. J Clin Pharmacol 2002; 42:71S-81S.
4. Mehra R, Moore BA, Crothers K, Tetrault J, Fiellin DA. The association between marijuana smoking and lung cancer: a systematic review. Arch Intern Med 2006; 166:1359-1367
5. Gaziano JM. Marijuana use among those at risk for cardiovascular events. Am Heart J 2008; 155: 395-396
6. Aryana A, Williams, MA. Marijuana as a trigger of cardiovascular events: speculation or scientific certainty? Int J Cardiol 2007; 118:141-144
7. Sidney S.Cardiovascular consequences of marijuana use. J Clin Pharmacol 2002; 42:64S-70S.
8. Afonso L,Mohammad T, Thatai D. Crack whips the heart: a review of the cardiovascular toxicity of cocaine. Am J Cardiol 2007; 100:1040-1043
9. Velasquez EM, Anand RC, Newman WP 3rd, Richard SS, Glancy DL. Cardiovascular complications associated with cocaine use. J La State Med Soc 2004; 156:302-310
10. Herning RI, Better W, Cadet JL. EEG of chronic marijuana users during abstinence: relationship to years of marijuana use, cerebral blood flow and thyroid function. Clin Neurophysiol 2008; 119:321-331
11. Griffing GT. Endocannabinoids-the brain's own marijuana-may be linked to the metabolic syndrome. MedGenMed 2006; 8:7.
12. WadlandWC, Ferenchick GS. Medical comorbidity in addictive disorders. Psychiatric Clinics ofNorth America 2004; 27:675-687
13. Spinks R, CaspersK, Langbehn D,Yucuis R, McKirgan LW, Arndt S, Pfalzgraf CJ, Cadoret R. Co-morbid health conditions at mid-life in the Iowa adoptees. Addict Behav 2007; 32:991-1002.
14. Bourque L, Tashkin D, Clark V, Schuler R. Demographic and health characteristics of heavy marijuana smokers in Los Angeles County. International Journal of Addiction 1991; 26:739-755
15. Eisen S, Chantarujikapong S, Xian H, Lyons, M, ToomeyR, TrueW, Scherrer J,Goldberg J, Tsuang M. Does marijuana use have residual adverse effects on self-reported health measures, socio-demographics and quality of life? A monozygotic co-twin control study in men. Addiction 2002; 97:1137-1144
16. Falck RS, Wang J, Carlson RG, Siegal HA. Crackcocaine use and health status as defined by the SF-36. Addict Behav 2000; 25:579-584
17. De Alba I, Samet JH, Saitz R. Burden of medical illness in drug- and alcohol-dependent persons without primary care. Am J Addict 2004; 13:33-45.
18. Yates W, Cadoret R, Troughton E. The Iowa Adoption Studies: methods and results. In: LaBuda M, Grigorenko E, eds. On the way to individuality: current methodological issues in behavioral genetics. Commack,NY: Nova Science Publishers, Inc., 1999:95-121.
19. Bucholz KK, Cadoret R, Cloninger CR, Dinwiddie SH, Hesselbrock VM, Nurnberger JI, Jr., Reich T, Schmidt I, Schuckit MA. A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. J Stud Alcohol 1994; 55: 149-158
20. Gronbaek M. Factors influencing the relation between alcohol and cardiovascular disease. Curr Opin Lipidol 2006; 17:17-21.
21. Rehm J, Sempos CT, Trevisan M. Alcohol and cardiovascular disease-more than one paradox to consider. Average volume of alcohol consumption, patterns of drinking and risk of coronary heart disease-a review. J Cardiovasc Risk 2003; 10:15-20.
22. Mukamal KJ, Chung H, Jenny NS, Kuller LH, Longstreth WT, Jr., Mittleman MA, Burke GL, Cushman M, Psaty BM, Siscovick DS. Alcohol consumption and risk of coronary heart disease in older adults: the Cardiovascular Health Study. J Am Geriatr Soc 2006; 54:30-37
23. Emberson JR, ShaperAG,Wannamethee SG,Morris RW,Whincup PH. Alcohol intake in middle age and risk of cardiovascular disease and mortality: accounting for intake variation over time. Am J Epidemiol 2005; 161:856-863
24. Friesema IH, Zwietering PJ, Veenstra MY, Knottnerus JA, Garretsen HF, Kester AD, Lemmens PH. The effect of alcohol intake on cardiovascular disease and mortality disappeared after taking lifetime drinking and covariates into account. Alcohol Clin Exp Res 2008; 32:645-651
25. Gupta R, Gurm H, Bartholomew JR. Smokeless tobacco and cardiovascular risk. Arch Intern Med 2004; 164:1845-1849
26. Arabi Z. Metabolic and cardiovascular effects of smokeless tobacco. J Cardiometab Syndr 2006; 1:345-350
27. Gupta BK, Kaushik A, Panwar RB, Chaddha VS, Nayak KC, Singh VB, Gupta R, Raja S. Cardiovascular risk factors in tobacco-chewers: a controlled study. J Assoc Physicians India 2007; 55:27-31.
28. Bakhru A, Erlinger TP. Smoking cessation and cardiovascular disease risk factors: results from the Third NationalHealth andNutrition Examination Survey. PLoS Med 2005; 2:e160.
29. Bullen C. Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease. Expert Rev Cardiovasc Ther 2008; 6:883-895
30. Gratziou C. Respiratory, cardiovascular and other physiological consequences of smoking cessation. Curr Med Res Opin 2009; 25:535-545
31. Wang JF, Ren X, DeAngelis J, Min J, Zhang Y, Hampton TG, Amende I, Morgan JP. Differential patterns of cocaine-induced organ toxicity in murine heart versus liver. Exp Biol Med (Maywood) 2001; 226:52-60.
32. Roberts SM, Harbison RD, James RC. Inhibition by ethanol of the metabolism of cocaine to benzoylecgonine and ecgonine methyl ester in mouse and human liver. Drug Metab Dispos 1993; 21:537-541
33. Alexandre PK, French MT, Matzger H, Weisner C. Addiction treatment history, medical services utilization, and cost: a longitudinal analysis of problem drinkers. J Addict Dis 2006; 25:105-120
34. Druss BG, von Esenwein SA. Improving general medical care for persons with mental and addictive disorders: systematic review. Gen Hosp Psychiatry 2006; 28:145-153
35. Friedmann PD, Hendrickson JC, Gerstein DR, Zhang Z, Stein MD. Do mechanisms that link addiction treatment patients to primary care influence subsequent utilization of emergency and hospital care? Med Care 2006; 44:8-15.
36. Jones RT. Cardiovascular system effects of marijuana. J Clin Pharmacol 2002; 42:58S-63S.
37. Ponto LL, O'Leary DS, Koeppel J, Block RI, Watkins GL, Richmond JC, Ward CA, Clermont DA, Schmitt BA, Hichwa RD. Effect of acute marijuana on cardiovascular function and central nervous system pharmacokinetics of [(15)O]water: effect in occasional and chronic users. J Clin Pharmacol 2004; 44:751-766